Tendencias del desarrollo de patentes de productos antiandrógenos para el tratamiento de tumores prostáticos

by Mayra Reyes, Luis Maqueira, Pedro C. Rodríguez, José A. Ruiz
Published 2005-01-01

Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule

by Xitlally Popa, Beatriz García, Karla P. Fuentes, Vivian Huerta, Karen Alvarez, Carmen E. Viada, Elia Neninger, Pedro C. Rodríguez, Zuyen González, Amnely González, Tania Crombet, Zaima Mazorra
Published 2020-01-01